Hormonal imbalances originating from the pituitary and adrenal gland disorders significantly affect metabolic regulation, stress response, and glucose homeostasis. Conditions such as Cushing’s syndrome, Addison’s disease, and acromegaly disrupt normal endocrine signaling, contributing to insulin resistance, hypertension, and cardiovascular complications. Advances in endocrinology have led to targeted therapies, including hormone replacement and receptor-specific drugs, to restore balance. Imaging technologies and molecular diagnostics have improved early detection, allowing for timely interventions. Understanding the connections between pituitary-adrenal dysfunction and metabolic diseases enables the development of more precise treatment strategies. Ongoing research continues to refine therapeutic options, offering new hope for patients with complex endocrine disorders.
Title : Diabetes reduction (pre-diabetes and type 2) with integrative medicine
F Buck Willis, IUHS School of Medicine, Saint Kitts and Nevis
Title : Adipose MTP deficiency protects against hepatic steatosis by upregulating PPAR activity
Sujith Rajan, NYU Long Island School of Medicine, United States
Title : Does winter melon (Benincasa hispida) improves nutritional values and ameliorating glycaemic parameters?
Wan Rosli Wan Ishak, Universiti Sains Malaysia, Malaysia
Title : Clinical applications of monitoring unmethylated insulin cfDNA associated with beta-cell death for diabetes and metabolic diseases
Clifford Morris, Kihealth, United States
Title : Diabetes and migration: Impact of internal displacement on the prevalence and management of diabetes in Les Cayes, South Haiti (2022-2024)
Berger Saintius, Field Epidemiology Training Program (FETP), Haiti
Title : Correlation between food insecurity and diabetes in the commune of Les Cayes (2021-2024)
Djeamsly Salomon, Field Epidemiology Training Program (FETP), Haiti